Freund's complete adjuvant induces arthritis in mice lacking a functional interferon-γ receptor by triggering tumor necrosis factor α-driven osteoclastogenesis

Arthritis and Rheumatism

Volumn 56, Issue 8, 2007, Pages 2595-2607

  Geboes, Lies ^a,c   De Klerck, Bert ^a   Van Balen, Maarten ^a   Kelchtermans, Hilde ^a   Mitera, Tania ^a   Boon, Louis ^b   De Wolf Peeters, Chris ^a   Matthys, Patrick ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b BIOCEROS   (Netherlands)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COLLAGEN; CYTOKINE; ETANERCEPT; FREUND ADJUVANT; GAMMA INTERFERON RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; IMMUNOREGULATION; IN VITRO STUDY; INCIDENCE; KNOCKOUT MOUSE; MALE; MOUSE; MYCOBACTERIUM BUTYRICUM; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; SPLEEN CELL; SYMPTOMATOLOGY; SYNOVIUM; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL RESPONSE MODIFIERS; BONE MARROW; BONE RESORPTION; CELL PROLIFERATION; FREUND'S ADJUVANT; IMMUNOGLOBULIN G; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTORS, INTERFERON; RECEPTORS, TUMOR NECROSIS FACTOR; SPLEEN; STIFLE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547772582     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22791     Document Type: Article

References (40)

1. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
2. Wooley PH, Chapedelaine JM. Immunogenetics of collagen-induced arthritis. Crit Rev Immunol 1987;8:1-22.
3. Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003;25:3-18.
4. Billiau A, Matthys P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 2001;70:849-60.
5. Mauri C, Feldmann M, Williams RO. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response. Arthritis Rheum 2003;48:839-45.
6. Holmdahl R, Lorentzen JC, Lu S, Olofsson P, Wester L, Holmberg J, et al. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 2001;184:184-202.
7. Knight B, Katz DR, Isenberg DA, Ibrahim MA, le Page S, Hutchings P, et al. Induction of adjuvant arthritis in mice. Clin Exp Immunol 1992;90:459-65.
8. Ratkay LG, Zhang L, Tonzetich J, Waterfield JD. Complete Freund's adjuvant induces an earlier and more severe arthritis in MRL-lpr mice. J Immunol 1993;151:5081-7.
9. Chillingworth NL, Donaldson LF. Characterisation of a Freund's complete adjuvant-induced model of chronic arthritis in mice. J Neurosci Methods 2003;128:45-52.
10. Yoshino S, Murata Y, Ohsawa M. Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4. J Immunol 1998;161:6904-8.
11. Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J Immunol 1997;158:5501-6.
12. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J Immunol 1997;158:5507-13.
13. + regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ. Arthritis Res Ther 2005;7:R402-15.
14. Chu CQ, Song Z, Mayton L, Wu B, Wooley PH. IFNγ deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vβ6 and Vβ8 in arthritic joints. Ann Rheum Dis 2003;62:983-90.
15. Guedez YB, Whittington KB, Clayton JL, Joosten LA, van de Loo FA, van den Berg WB, et al. Genetic ablation of interferon-γ up-regulates interleukin-1β expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum 2001;44:2413-24.
16. + myeloid cells. J Immunol 1999;163:3503-10.
17. Campbell IK, Hamilton JA, Wicks IP. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 2000;30:1568-75.
18. De Klerck B, Carpentier I, Lories RJ, Habraken Y, Piette J, Carmeliet G, et al. Enhanced osteoclast development in collagen-induced arthritis in interferon-γ receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis. Arthritis Res Ther 2004;6:R220-31.
19. Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, et al. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 2006;24:33-63.
20. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006;12:17-25.
21. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998;95:3597-602.
22. Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, et al. Tumor necrosis factor α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 2002;46:785-92.
23. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, et al. Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest 2002;110:1419-27.
24. high osteoclast precursors in tumor necrosis factor α-transgenic mice. Arthritis Rheum 2004;50:265-76.
25. Yao Z, Li P, Zhang Q, Schwarz EM, Keng P, Arbini A, et al. Tumor necrosis factor-α increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem 2006;281:11846-55.
26. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, et al. Immune response in mice that lack the interferon-γ receptor. Science 1993;259:1742-5.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
28. T Method. Methods 2001;25:402-8.
29. Nissler K, Pohlers D, Huckel M, Simon J, Brauer R, Kinne RW. Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann Rheum Dis 2004;63:1470-7.
30. Matthys P, Lories RJ, de Klerck B, Heremans H, Luyten FP, Billiau A. Dependence on interferon-γ for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum 2003;48:2983-8.
31. -/- mice: role for IFN-γ in activating apoptosis of hepatocytes. J Immunol 1997;159:1418-28.
32. Waksman BH. Immune regulation in adjuvant disease and other arthritis models: relevance to pathogenesis of chronic arthritis. Scand J Immunol 2002;56:12-34.
33. Schett G, Redlich K, Hayer S, Zwerina J, Bolon B, Dunstan C, et al. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum 2003;48:2042-51.
34. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med 1999;190:1741-54.
35. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
36. Billiau A. Interferon-γ: biology and role in pathogenesis. Adv Immunol 1996;62:61-130.
37. Murray PJ, Young RA, Daley GQ. Hematopoietic remodeling in interferon-γ-deficient mice infected with mycobacteria. Blood 1998;91:2914-24.
38. Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ. TNFα potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002;143:1108-18.
39. Williams RO, Whyte A. Anti-CD4 monoclonal antibodies suppress murine collagen-induced arthritis only at the time of primary immunisation. Cell Immunol 1996;170:291-5.
40. Williams RO, Feldmann M, Maini RN. Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor α. Ann Rheum Dis 2000;59 Suppl 1:i75-80.